Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão

Detalhes bibliográficos
Autor(a) principal: Ana Cláudia Herdeiro Vaz de Moura
Data de Publicação: 2020
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/128754
Resumo: Abstract Autism spectrum disorder is a brain-based neurodevelopmental disorder characterized by impairments in social communication and by the presence of restricted, repetitive patterns of behaviour and interests. It has its onset in early childhood and significantly impacts the children and the family lives. Irritability and aggression are common co-occurring psychiatric conditions in autism spectrum disorder (25%) and the usage of atypical antipsychotics might be considered. The goal of the present review is to analyse the short and long-term efficacy and safety of risperidone, aripiprazole and paliperidone in the treatment of irritability in children and adolescents with autism spectrum disorder. A literature review was performed, searching PubMed and Cochrane Database of Systemic Reviews, using the Medical Subject Headings. The studies considered in this review show their efficacy in the short and long-term treatment. Although atypical antipsychotics have a safer profile than typical antipsychotics, they are associated with a significant weight gain and metabolic complications that shouldn't be overlooked. During antipsychotic treatment, it would be prudent to conduct a metabolic screening and implement preventive measures such as a calorically appropriated diet and physical exercise to reduce weight gain. In conclusion, the use of antipsychotics should be reserved for severe and enduring cases of irritability, when behavioural interventions have been tried and failed and when harm to self and others imminently exceeds the risk of harm from medication.
id RCAP_c20fc16187b90188c56f9f8819c3d4ae
oai_identifier_str oai:repositorio-aberto.up.pt:10216/128754
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma RevisãoMedicina clínicaClinical medicineAbstract Autism spectrum disorder is a brain-based neurodevelopmental disorder characterized by impairments in social communication and by the presence of restricted, repetitive patterns of behaviour and interests. It has its onset in early childhood and significantly impacts the children and the family lives. Irritability and aggression are common co-occurring psychiatric conditions in autism spectrum disorder (25%) and the usage of atypical antipsychotics might be considered. The goal of the present review is to analyse the short and long-term efficacy and safety of risperidone, aripiprazole and paliperidone in the treatment of irritability in children and adolescents with autism spectrum disorder. A literature review was performed, searching PubMed and Cochrane Database of Systemic Reviews, using the Medical Subject Headings. The studies considered in this review show their efficacy in the short and long-term treatment. Although atypical antipsychotics have a safer profile than typical antipsychotics, they are associated with a significant weight gain and metabolic complications that shouldn't be overlooked. During antipsychotic treatment, it would be prudent to conduct a metabolic screening and implement preventive measures such as a calorically appropriated diet and physical exercise to reduce weight gain. In conclusion, the use of antipsychotics should be reserved for severe and enduring cases of irritability, when behavioural interventions have been tried and failed and when harm to self and others imminently exceeds the risk of harm from medication.2020-06-182020-06-18T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/10216/128754TID:202612333engAna Cláudia Herdeiro Vaz de Mourainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T16:03:34Zoai:repositorio-aberto.up.pt:10216/128754Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:37:25.591773Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
title Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
spellingShingle Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
Ana Cláudia Herdeiro Vaz de Moura
Medicina clínica
Clinical medicine
title_short Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
title_full Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
title_fullStr Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
title_full_unstemmed Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
title_sort Antipsicóticos atípicos no tratamento da irritabilidade severa em crianças e adolescentes com perturbação do espectro do autismo: Uma Revisão
author Ana Cláudia Herdeiro Vaz de Moura
author_facet Ana Cláudia Herdeiro Vaz de Moura
author_role author
dc.contributor.author.fl_str_mv Ana Cláudia Herdeiro Vaz de Moura
dc.subject.por.fl_str_mv Medicina clínica
Clinical medicine
topic Medicina clínica
Clinical medicine
description Abstract Autism spectrum disorder is a brain-based neurodevelopmental disorder characterized by impairments in social communication and by the presence of restricted, repetitive patterns of behaviour and interests. It has its onset in early childhood and significantly impacts the children and the family lives. Irritability and aggression are common co-occurring psychiatric conditions in autism spectrum disorder (25%) and the usage of atypical antipsychotics might be considered. The goal of the present review is to analyse the short and long-term efficacy and safety of risperidone, aripiprazole and paliperidone in the treatment of irritability in children and adolescents with autism spectrum disorder. A literature review was performed, searching PubMed and Cochrane Database of Systemic Reviews, using the Medical Subject Headings. The studies considered in this review show their efficacy in the short and long-term treatment. Although atypical antipsychotics have a safer profile than typical antipsychotics, they are associated with a significant weight gain and metabolic complications that shouldn't be overlooked. During antipsychotic treatment, it would be prudent to conduct a metabolic screening and implement preventive measures such as a calorically appropriated diet and physical exercise to reduce weight gain. In conclusion, the use of antipsychotics should be reserved for severe and enduring cases of irritability, when behavioural interventions have been tried and failed and when harm to self and others imminently exceeds the risk of harm from medication.
publishDate 2020
dc.date.none.fl_str_mv 2020-06-18
2020-06-18T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/128754
TID:202612333
url https://hdl.handle.net/10216/128754
identifier_str_mv TID:202612333
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136281737822209